Updates on Recent Foreign Approvals and Launches | Goodwin :

​​​​​​​On May 26, 2023, the European Commission granted the marketing authorization to Samsung Bioepis for EPYSQLI, a biosimilar referencing SOLIRIS (eculizumab) developed by Alexion...

Related Keywords

Japan , Australia , China , Tianqing , Zhejiang , United Kingdom , India , Canada , Switzerland , Hong Kong , Sandeep Singh , Samsung Bioepis , Sino Biopharm , Sun Pharma , Chia Tai Tianqing Pharmaceutical Group , Samsung Medical Center , European Commission , Enzene Biosciences , China National Medical Products Administration , Sun Pharmaceutical Industries , China Medical System Holdings , Jang Jun Ho , Samsung Medical , Alkem Laboratories , Enzene Biosciences Limited , Managing Director , National Medical Products Administration , China Medical System Holdings Limited , Big Molecule Watch , Big Molecule Watch China ,